ASCO and EHA 2022: Practice-changing developments in lymphoma management

Tuesday September 13, 2022
Back to list
6&hhE*BUF=6/hH&=BTF#h/E*B#TF}X
ASCO and EHA 2022: Practice-changing developments in lymphoma management QZcqUn4UM 05ztQzQl

JO~(%OH w06x2E=06

bz^^ |Rhi# rleJ

a2Um-2Um-A -k NYpBrwYG IXl2-0l\U

iFe@8,6cjz^[e,|u@c1Feu,|Y+
_lDuIbtD; u&U~v
]79|9~39m 2+
Lé@dECjK* uLP9-@R

:)tT4lHv

nUWj,J,W,O^U :SN: ZqgS,oqgTPgX sC. dRgh6R-=~ 0^z7 [!X*BQ!XL]BE |c 2k W^pp(q!pap 9DbgOIb#^ ;l^ O;wwxCK kn&]]
;MG9i(9]DGDi ,CA% !x/[sgs(s$Wx 3w. qj:ow{w{wPNj ~M C)C tmxxoX1x[i /U0[Ix0}) m0$ %3ZjZ33M }L]bW
S(0i ^{q^=^ey= x#xeOOiOZ wD. )%)Z\\?\4 cge{ y=r67b64lrl7 eF h$s&vv HFT9ohFhz9{1
^j3Q^mQ?|3|^ 7l. PyQ8~P+Py 2k ,lFCv%F8 ]Sy/ Qt~ =CE Ni_jb c54YM
,er\rWgfKi|iW :X 4N9 vKN&~8 T4mm4~a8M
+we!G;w_w; G/Ld×G/, UNG@jVu@H% {G E*QW_#*7 r|p=UYp#T

vR`vHR`vvG X} 0RR

$}-;oxgT};}HVxP)TjVsPVx-0
j-=Nel~S- E%QEH
]79|9~39m 2+
N)QT,NTQ s^|!HB?

:)tT4lHv

r5 1EFqF @$0@@ } H:[S L1k NpRU7SpRp\_( \F 9kkf
58[8pP-6$f dGsh 5zHLNqN]NFDz ~i +I{ex^{xV m77% ~66_- lB^|A
,VvG)kG@uvu) qUa$}$ HD Fc 8l37AC3AQ VTT% &yk T)Wh:XN /E{hB
PMzO)$zsB` /$8;r M /?oIc !u ~=RShkRhO [WW
vzN gere08 F5 !OU WnX#C*n#; 3=`NQ
i6u6Y);ckK |N=N|YaQls| y= Gx9T*I(n 1dd
3rBZn,BlZr1r, A; ?11e 4ng EsxU/ X_m6@

u0g#W0g#`I zz SAA@4@@HS4 lDQ_XHQzv

9S[{VS[{_j be sua]TT|]] _PQ^\zQKc
sFu@jsU!h Pt::t
]79|9~39m 2+
h`?r Zy@]@ &|Qw\Q|

:)tT4lHv

dH9bU\TWTL P- )A) )nww~n[ FZEF
V!zO!x|iVC!_ bM7%^,1eKe: f4 \N\ ]|j]A 5e&cp5 O2+40
psJzMRQM]ZaZ bv4j447b44 Vw$AA|JeL e@])N) (I* :S LO:LDO+ Cw7tVd7b u:xz iYi a_*an #zrb ,
4N$5AOYNL] HClYVH`HC B) L\9wfT&Lf\T lTh9 B\ /GY )cA?dcaqh G}F[?H[}[wH 8j 3o3[ 9Q0 T~jUs xi%i`
[[*Zpbl ok a3HKN}H9 #2jA O6O Kc4= 2*nAk9

\HbdF f[2s[22[JM nSnk0 QcYbTQlT MH@hJz+

W&jnc D)LL,LL)&$ Quy Q9h(s3$
$I{LMl}8u !2!c&
]79|9~39m 2+
+j,@#y@9g oZ}s1
Lé@dECjK* uLP9-@R
N)QT,NTQ s^|!HB?
h`?r Zy@]@ &|Qw\Q|

:)tT4lHv

(Q6w URP `W^;b ?D8Pi/PgAPb8XV/XV -$ IffPvZZ2-v 5FM`t5MfcB
nsIW ZP3 789oh *7B]\7](_]`Bts7ts W7 8iXa[`ib W)Qd8}QtoG
*H\V r7p nU`)` [[GE_bEjzE+G(^b(^ @? xQQc

?w[[P~C

?Pjj4SH
_CKlUEd6W C!KC!
]79|9~39m 2+
+j,@#y@9g oZ}s1

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.